Health on MSN3h
Zepbound Is Now Available in Additional Doses at Lower Costs
Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
Oncology Nurse Advisor1d
Disitamab Vedotin Plus Toripalimab Demonstrates Activity in HER2-Expressing MIBC
Neoadjuvant disitamab vedotin plus perioperative toripalimab showed promising efficacy and acceptable safety in patients with HER2-expressing MIBC, according to Xinan Sheng, MD.
Clinical Trials Arena on MSN57m
Persica’s antibiotic-based drug alleviates lower back pain in Phase Ib trial
Evidence has shown that 25% of patients with chronic lower back pain could be suffering from an infection in the disc space.
MarketWatch2d
U.K. 30 Year Gilt
Indonesia 30 Year Government Bond 0.0000 6.9950% ...
BioWorld1d
Chimerix brings a rare cancer drug to the $935M Jazz party
Jazz Pharmaceuticals plc is buying Chimerix Inc. for $8.55 a share, bringing the deal in at about $935 million. Jazz expands its cancer pipeline with the new acquisition’s lead candidate, dordaviprone ...
Medscape6d
Efficacy, Safety and Tolerability of Escitalopram in Doses up to 50 mg in Major Depressive Disorder (MDD)
Twenty-one patients (35%) achieved remission with 8 of the 21 patients (38%) needing the 50 mg dose to achieve remission. Median time to remission was 24 weeks and median dose in remission was 30 ...
Bloomberg L.P.4d
Egyptian Exchange EGX 30 Price Index
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...